Provided are a novel method for treating cancer, said method exhibiting a remarkably excellent antitumor effect with little side effect, and an immunostimulant. An antitumor agent and an immunostimulant, characterized by comprising an azabicyclo compound and an immune checkpoint molecule regulator which are to be concomitantly administered.